NCT06622005 SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06616597 Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer Status RECRUITING Phase PHASE2
NCT06616584 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) Status RECRUITING Phase PHASE2/PHASE3
NCT06616220 Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery Status COMPLETED Phase PHASE4
NCT06615479 A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) Status RECRUITING Phase PHASE3
NCT06603662 Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department Status RECRUITING Phase PHASE4
NCT06598059 Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array Status ACTIVE_NOT_RECRUITING Phase NA
NCT06577025 A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06574048 Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06561854 Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone Status RECRUITING Phase PHASE3
NCT06554626 Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL Status RECRUITING Phase PHASE2
NCT06533748 Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma Status RECRUITING Phase PHASE2
NCT06527976 Dexamethasone Versus Demedetomidine Addition for Adductor Canal Block Status COMPLETED Phase NA
NCT06518551 Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM Status RECRUITING Phase PHASE1/PHASE2
NCT06508983 A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients Status RECRUITING Phase PHASE3
NCT06505369 Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients Status RECRUITING Phase PHASE2
NCT06496997 A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome Status RECRUITING Phase PHASE2/PHASE3
NCT06489808 Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL Status RECRUITING Phase PHASE2
NCT06470100 Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty Status COMPLETED Phase PHASE4